Entinostat (MS-275) Mechanism of Action: HDAC1 Inhibition in Breast Cancer Cell Research

Entinostat (MS-275) MOA:Targeting HDAC1/Estrogen Receptor Signaling Pathway for Breast Cancer

🎯 check Entinostat (MS-275) product page

Entinostat (MS-275) is a potent, selective class I HDAC inhibitor. It affects Wnt, Hippo, and STAT signaling by inducing histone hyperacetylation and altering gene transcription, effectively inhibiting tumor proliferation and promoting apoptosis and anti-tumor immunity.

Primary Applications and Mechanism of Action